The Healing Co (The Healing Co) Risk Assessment

View and export this data going back to 2009. Start your Free Trial

What is The Healing Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of The Healing Co is: No Data: Cannot be evaluated.

Competitive Comparison of The Healing Co's Risk Assessment

For the Health Information Services subindustry, The Healing Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Healing Co's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, The Healing Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where The Healing Co's Risk Assessment falls into.

The Healing Co (OTCPK:HLCO) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

The Healing Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of The Healing Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

The Healing Co (The Healing Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » The Healing Co Inc (OTCPK:HLCO) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

135 W 50th Street, 2nd Floor, New York, NY, USA, 10020

Website

https://www.healingcompany.com

The Healing Co Inc is a health and wellness company that has identified the need for a change to healthcare, where conventional medicine and alternative healing can both be drawn on to provide a world of integrated healing encompassing conventional medicine and alternative medicine. The company has three operating segments which are E-commerce sales of health and wellness products, Sales of memberships to our wellness app, and Support for our licensed wellness experiences.

Executives

Steven John Barr	director	P.O. BOX 789, MOUNT VERNON OH 43050
Ameeth Sankaran	director	6404 PEMBERTON DRIVE, DALLAS TX 75230
Kay Koplovitz	director	KOPLOVITZ & CO. LLC, 145 CENTRAL PARK WEST, APT 24C, NEW YORK NY 10023
Anabel Oelmann	director	C/O HAUSPLUS, HOHENZOLLERNDAMM 125/126, BERLIN 2M 14199
Simon Belsham	director, officer: CEO, President	1101 GRAND STREET, APT. 302, HOBOKEN NJ 07030
Justin Figgins	officer: CFO	81 ENNERDALE ROAD, RICHMOND SURREY X0 TW9 2DN
Wanja Oberhof	10 percent owner	LINIENSTRASSE 86, BERLIN 2M 10119
Demetri Argyropoulos	10 percent owner	5940 SOUTH RAINBOW BLVD, SUITE 400/PMB 32031, LAS VEGAS NV 89118
Steven Bartlett	director	7 CHAPPEL LOFTS, 10 BELMONT STREET, LONDON X0 NW18HH
Jeffrey Taylor	director, 10 percent owner, officer: President/Secretary/Treasurer	711 S. CARSON STREET, CARSON CITY NV 89701